ReviewESMO open2024
HER2DX genomic test in early-stage HER2-positive breast cancer.
S M Tolaney et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
19 papers cite it
this papertrialcites it
ReviewESMO open2024
S M Tolaney et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.